These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6249559)
1. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat. Innemee HC; Hermans AJ; van Zwieten PA Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559 [TBL] [Abstract][Full Text] [Related]
2. The influence of clonidine on intraocular pressure. Innemee HC; van Zwieten PA Doc Ophthalmol; 1979 Mar; 46(2):309-15. PubMed ID: 477484 [TBL] [Abstract][Full Text] [Related]
3. The influence of acute and chronic cervical sympathectomy on the ocular hypotensive effect of clonidine. Innemee HC; van Ommeren JD; van Zwieten PA Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Nov; 212(1):11-8. PubMed ID: 317231 [TBL] [Abstract][Full Text] [Related]
4. The central ocular hypotensive effect of clonidine. Innemee HC; van Zwieten PA Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Apr; 210(2):93-102. PubMed ID: 312040 [TBL] [Abstract][Full Text] [Related]
5. The distribution in the eye and the effect on intraocular pressure of clonidine. Innemee HC; van Zwieten PA Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Jan; 209(3):189-98. PubMed ID: 311173 [TBL] [Abstract][Full Text] [Related]
6. Interaction between delta-9-tetrahydrocannabinol and indomethacin. Green K; Kearse EC; McIntyre OL Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids. Liu JH; Dacus AC Arch Ophthalmol; 1987 Feb; 105(2):245-8. PubMed ID: 3813958 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid. Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol. Colasanti BK J Ocul Pharmacol; 1990; 6(4):259-69. PubMed ID: 1965836 [TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene. Colasanti BK; Powell SR; Craig CR Exp Eye Res; 1984 Jan; 38(1):63-71. PubMed ID: 6323206 [TBL] [Abstract][Full Text] [Related]
11. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol. Colasanti BK; Brown RE; Craig CR Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513 [TBL] [Abstract][Full Text] [Related]
12. The influence of clonidine on intraocular pressure after topical application to the eyes of anesthetized cats. Innemee HC; Hermans AJ; van Zwieten PA Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Nov; 212(1):19-27. PubMed ID: 317232 [TBL] [Abstract][Full Text] [Related]
13. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input. Colasanti BK; Powell SR J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632 [TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure, ocular toxicity and neurotoxicity in response to 11-hydroxy-delta 9-tetrahydrocannabinol and 1-nantradol. Colasanti BK J Ocul Pharmacol; 1985; 1(2):123-35. PubMed ID: 2851633 [TBL] [Abstract][Full Text] [Related]
15. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. Cooler P; Gregg JM South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423 [TBL] [Abstract][Full Text] [Related]
16. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979 [TBL] [Abstract][Full Text] [Related]
17. Involvement of central alpha-adrenoceptors in the hypotensive and bradycardic effects of (--)-delta 9-trans-tetrahydrocannabinol. Lokhandwala MF; Pariani HK; Buckley JP; Jandhyala BS Eur J Pharmacol; 1977 Mar; 42(2):107-12. PubMed ID: 191263 [TBL] [Abstract][Full Text] [Related]
18. Hypotensive drugs: Peripheral versus central effects. Zaimis E Contrib Nephrol; 1977; 8():142-50. PubMed ID: 891210 [No Abstract] [Full Text] [Related]
19. Study of central regulation of intraocular pressure using ventriculocisternal perfusion. Liu JH; Neufeld AH Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):136-43. PubMed ID: 4038694 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists. Park KH; Long JP; Cannon JG J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]